# Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

> **NCT06160128** · — · RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 400000 (estimated)

## Conditions studied

- COVID-19, SARS-CoV-2 Infection
- RSV
- Influenza

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06160128
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-26
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 400000 (ESTIMATED)
- **Last updated:** 2026-02-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06160128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06160128, "Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06160128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*